Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  News  >  Companies  >  All News

News : Companies
Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Intersect ENT, Inc. (XENT)

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/17/2019 | 07:32pm EDT

NEW YORK, May 17, 2019 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a class action lawsuit has been filed against Intersect ENT, Inc. (“Intersect ENT” or the “Company”) (Nasdaq: XENT) in the United States District Court for the Northern District of California on behalf of those who purchased or acquired the securities of Intersect ENT between August 1, 2018 through May 6, 2019, inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Rule 10b-5 promulgated thereunder.

The Complaint alleges that Defendants made false and/or misleading statements and/or failed to disclose that: (1) Intersect ENT lacked adequate reimbursement representatives to ensure physicians had access to SINUVA, Intersect ENT’s sinus implant; (2) Intersect ENT’s sales force would focus on ensuring reimbursement; (3) Intersect ENT’s sales representatives were less focused on driving sales; (4) physicians were less likely to adopt Intersect ENT’s SINUVA due to transaction costs associated with seeking reimbursement; (5) Intersect ENT would increase staffing to address these issues; and (6) as a result of the foregoing, Defendants’ positive statements about Intersect ENT’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.

Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm prior to the July 15, 2019 lead plaintiff motion deadline.  A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.  If you wish to discuss your rights or interests regarding this class action, please contact Thomas J. McKenna, Esq. or Gregory M. Egleston, Esq. of Gainey McKenna & Egleston at (212) 983-1300, or via e-mail at tjmckenna@gme-law.com or gegleston@gme-law.com.

Please visit our website at http://www.gme-law.com for more information about the firm.


© GlobeNewswire 2019
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news "Companies"
05:31pFILO MINING : Files Notice of Annual General and Special Meeting of Shareholders to be Held June 20 2019
AQ
05:31pSELF STORAGE : Argus Broker Affiliate Announces Sale of Kansas Self-Storage Facility
AQ
05:31pFREEPORT-MCMORAN INC : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
05:31pGX ACQU : Acquisition Corp. Announces Closing of $287,500,000 Initial Public Offering
AQ
05:31pGALECTIN THERAPEUTICS : Reports Alternate Price of Common Stock in Rights Offering
AQ
05:31pMAJESCO : CEO Adam Elster Presents at Needham & Company's Emerging Technology Conference and B. Riley's Annual Investor Conference
BU
05:30pMEDIPHARM LABS : UPDATE - New York City Icahn School of Medicine at Mount Sinai and Renowned Global Researcher Dr. Hurd, Select MediPharm Labs to Support 500 Patient Major Clinical Study And “CBD International Consortium” to Develop Treatment of Opioid Addiction
AQ
05:30pGRAIN HIGHLIGHTS : Top Stories of the Day
DJ
05:29pAT&T : The best AT&T plans in May 2019
AQ
05:29pHEMISPHERE MEDIA GROUP, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
Latest news "Companies"
Advertisement